HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Moriyama Selected Research

Immunoglobulin E (IgE)

10/2013Risk factors for olfactory dysfunction in chronic rhinosinusitis.
1/2013Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation.
1/2008Chronic rhinosinusitis: risk factors for the recurrence of chronic rhinosinusitis based on 5-year follow-up after endoscopic sinus surgery.
11/2002[Allergic fungal sinusitis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Moriyama Research Topics

Disease

10Asthma (Bronchial Asthma)
12/2013 - 04/2003
9Interstitial Lung Diseases (Interstitial Lung Disease)
01/2017 - 10/2003
9Neoplasms (Cancer)
01/2012 - 06/2002
8Lung Diseases (Lung Disease)
12/2022 - 07/2007
8Nasal Polyps (Nasal Polyp)
12/2013 - 05/2004
6Rhinosinusitis
01/2013 - 12/2008
5Dyspnea (Shortness of Breath)
11/2023 - 01/2010
5Inflammation (Inflammations)
02/2023 - 10/2006
4Pulmonary Fibrosis (Fibrosing Alveolitis)
06/2013 - 09/2009
4Sinusitis
12/2012 - 04/2003
4Squamous Cell Carcinoma of Head and Neck
01/2011 - 06/2002
3Cognitive Dysfunction
10/2023 - 01/2017
3Granuloma
02/2023 - 01/2016
3Pneumoconiosis
01/2017 - 11/2011
3Otitis Media
03/2016 - 04/2006
3Fibrosis (Cirrhosis)
01/2016 - 09/2009
3Lung Injury
06/2013 - 11/2007
3Fabry Disease (Fabry's Disease)
01/2013 - 12/2009
3Cholesteatoma
01/2013 - 09/2003
3Infections
08/2010 - 10/2006
3Respiratory Tract Infections (Respiratory Tract Infection)
08/2007 - 04/2006
2Silicosis
01/2022 - 11/2011
2Pulmonary Alveolar Proteinosis
07/2019 - 01/2015
2Respiratory Insufficiency (Respiratory Failure)
01/2019 - 01/2014
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
10/2017 - 11/2016
2Pneumonia (Pneumonitis)
11/2016 - 01/2016
2Epistaxis (Nosebleed)
02/2014 - 02/2012
2Polyps
10/2013 - 01/2008
2Pituitary Neoplasms (Pituitary Adenoma)
01/2013 - 03/2007
2Hearing Loss (Hearing Impairment)
01/2013 - 06/2010
2Pain (Aches)
02/2012 - 02/2012
2Headache (Headaches)
02/2012 - 03/2006
2Allergic Rhinitis
01/2012 - 01/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2011 - 01/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2006 - 06/2002
2Polymyositis
10/2003 - 05/2002
2Dermatomyositis (Dermatopolymyositis)
10/2003 - 05/2002
1Emphysema
02/2023
1Febrile Seizures (Febrile Seizure)
01/2023
1Hyperthermia
01/2023
1Foreign-Body Granuloma (Granuloma, Foreign Body)
12/2022
1Hypoxia (Hypoxemia)
01/2022
1Pleural Effusion (Pleural Effusions)
01/2022
1Epilepsy (Aura)
01/2021
1Cough
07/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019
1Amyloidosis
05/2018
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2018
1Organizing Pneumonia
05/2018

Drug/Important Bio-Agent (IBA)

5hard metalIBA
01/2015 - 07/2007
4Oxygen (Dioxygen)IBA
11/2023 - 01/2022
4Silicon Dioxide (Silica)FDA LinkGeneric
07/2019 - 11/2011
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2013 - 05/2004
4Immunoglobulin E (IgE)IBA
10/2013 - 11/2002
3SiliconIBA
01/2022 - 01/2014
3AluminumIBA
01/2017 - 01/2014
3Proteins (Proteins, Gene)FDA Link
01/2015 - 05/2004
3SteroidsIBA
01/2014 - 01/2008
3Prednisolone (Predate)FDA LinkGeneric
01/2014 - 10/2003
3Bleomycin (Blenoxane)FDA LinkGeneric
06/2013 - 11/2007
3MacrolidesIBA
02/2012 - 04/2003
2Adrenal Cortex Hormones (Corticosteroids)IBA
05/2018 - 06/2011
2Sirolimus (Rapamycin)FDA Link
10/2017 - 11/2016
2IronIBA
01/2016 - 01/2014
2CytokinesIBA
09/2015 - 04/2007
2TungstenIBA
03/2014 - 07/2007
2tungsten carbide (tungsten carbide (WC))IBA
01/2014 - 07/2007
2AntibodiesIBA
12/2012 - 10/2003
2Anti-Bacterial Agents (Antibiotics)IBA
02/2012 - 02/2009
2ErbB Receptors (EGF Receptor)IBA
01/2012 - 09/2009
2AllergensIBA
01/2011 - 01/2011
2EnzymesIBA
12/2009 - 06/2002
2bu-zhong-yi-qi-tangIBA
11/2007 - 11/2006
2Anti-Infective Agents (Microbicides)IBA
08/2007 - 10/2006
2Penicillins (Penicillin)FDA Link
10/2006 - 04/2006
1indium tin oxideIBA
02/2023
1IndiumIBA
02/2023
1CholesterolIBA
02/2023
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2023
1Polytetrafluoroethylene (Teflon)FDA Link
12/2022
1PowdersIBA
07/2019
1nintedanibIBA
01/2019
1yokukansankachimpihangeIBA
01/2019
1Yi-Gan SanIBA
01/2019
1Plant ExtractsIBA
01/2019
1Amyloid (Amyloid Fibrils)IBA
05/2018
1Congo RedIBA
05/2018
1Dasatinib (BMS 354825)FDA Link
05/2018
1Imatinib Mesylate (Gleevec)FDA Link
05/2018
1nilotinibFDA Link
05/2018

Therapy/Procedure

16Therapeutics
11/2023 - 04/2003
5Operative Surgical Procedures
12/2012 - 09/2003
3Drug Therapy (Chemotherapy)
06/2011 - 08/2004
2Activities of Daily Living (ADL)
11/2023 - 10/2023
2Aftercare (After-Treatment)
01/2013 - 10/2003
2Radiotherapy
01/2011 - 08/2010
2Endoscopes
02/2009 - 12/2008
2Conservative Treatment
05/2006 - 08/2003
1Induced Hyperthermia (Thermotherapy)
01/2023
1Anesthesia
01/2021